vs
CAPITAL CITY BANK GROUP INC（CCBG）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是CAPITAL CITY BANK GROUP INC的1.2倍（$75.5M vs $63.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 6.0%），CAPITAL CITY BANK GROUP INC自由现金流更多（$80.0M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 6.0%）
德克萨斯首都银行是一家总部位于得克萨斯州达拉斯的银行，在得克萨斯州所有主要城市均设有网点，其母公司控股公司为得克萨斯首都银行控股集团，同时该机构还运营着纯线上银行部门Bask Bank。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
CCBG vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.2倍
$63.5M
营收增速更快
PBYI
高出21.7%
6.0%
自由现金流更多
CCBG
多$65.6M
$14.4M
两年增速更快
PBYI
近两年复合增速
6.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $63.5M | $75.5M |
| 净利润 | $13.7M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 29.3% | 22.7% |
| 净利率 | 21.6% | — |
| 营收同比 | 6.0% | 27.7% |
| 净利润同比 | 4.7% | — |
| 每股收益（稀释后） | $0.80 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCBGPBYI
| Q4 25 | $63.5M | $75.5M | ||
| Q3 25 | $65.9M | $54.5M | ||
| Q2 25 | $63.2M | $52.4M | ||
| Q1 25 | $61.5M | $46.0M | ||
| Q4 24 | $59.9M | $59.1M | ||
| Q3 24 | $59.7M | $80.5M | ||
| Q2 24 | $58.9M | $47.1M | ||
| Q1 24 | $56.5M | $43.8M |
净利润CCBGPBYI
| Q4 25 | $13.7M | — | ||
| Q3 25 | $15.9M | $8.8M | ||
| Q2 25 | $15.0M | $5.9M | ||
| Q1 25 | $16.9M | $3.0M | ||
| Q4 24 | $13.1M | — | ||
| Q3 24 | $13.1M | $20.3M | ||
| Q2 24 | $14.2M | $-4.5M | ||
| Q1 24 | $12.6M | $-4.8M |
毛利率CCBGPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率CCBGPBYI
| Q4 25 | 29.3% | 22.7% | ||
| Q3 25 | 32.0% | 17.6% | ||
| Q2 25 | 31.7% | 12.7% | ||
| Q1 25 | 35.8% | 8.7% | ||
| Q4 24 | 29.0% | 22.6% | ||
| Q3 24 | 26.1% | 27.4% | ||
| Q2 24 | 29.3% | -4.6% | ||
| Q1 24 | 27.2% | -5.3% |
净利率CCBGPBYI
| Q4 25 | 21.6% | — | ||
| Q3 25 | 24.2% | 16.2% | ||
| Q2 25 | 23.8% | 11.2% | ||
| Q1 25 | 27.4% | 6.5% | ||
| Q4 24 | 21.9% | — | ||
| Q3 24 | 22.0% | 25.2% | ||
| Q2 24 | 24.0% | -9.6% | ||
| Q1 24 | 22.2% | -11.0% |
每股收益（稀释后）CCBGPBYI
| Q4 25 | $0.80 | $0.26 | ||
| Q3 25 | $0.93 | $0.17 | ||
| Q2 25 | $0.88 | $0.12 | ||
| Q1 25 | $0.99 | $0.06 | ||
| Q4 24 | $0.78 | $0.40 | ||
| Q3 24 | $0.77 | $0.41 | ||
| Q2 24 | $0.83 | $-0.09 | ||
| Q1 24 | $0.74 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $552.9M | $130.3M |
| 总资产 | $4.4B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资CCBGPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务CCBGPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益CCBGPBYI
| Q4 25 | $552.9M | $130.3M | ||
| Q3 25 | $540.6M | $115.3M | ||
| Q2 25 | $526.4M | $104.7M | ||
| Q1 25 | $512.6M | $97.1M | ||
| Q4 24 | $495.3M | $92.1M | ||
| Q3 24 | $476.5M | $71.1M | ||
| Q2 24 | $461.0M | $48.5M | ||
| Q1 24 | $448.3M | $51.0M |
总资产CCBGPBYI
| Q4 25 | $4.4B | $216.3M | ||
| Q3 25 | $4.3B | $202.9M | ||
| Q2 25 | $4.4B | $194.9M | ||
| Q1 25 | $4.5B | $196.2M | ||
| Q4 24 | $4.3B | $213.3M | ||
| Q3 24 | $4.2B | $220.7M | ||
| Q2 24 | $4.2B | $205.0M | ||
| Q1 24 | $4.3B | $214.1M |
负债/权益比CCBGPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $87.6M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $80.0M | $14.4M |
| 自由现金流率自由现金流/营收 | 126.1% | 19.1% |
| 资本支出强度资本支出/营收 | 12.0% | 0.0% |
| 现金转化率经营现金流/净利润 | 6.39× | — |
| 过去12个月自由现金流最近4个季度 | $150.1M | $41.7M |
8季度趋势，按日历期对齐
经营现金流CCBGPBYI
| Q4 25 | $87.6M | $14.4M | ||
| Q3 25 | $21.6M | $9.7M | ||
| Q2 25 | $32.6M | $14.1M | ||
| Q1 25 | $21.9M | $3.6M | ||
| Q4 24 | $63.6M | $15.6M | ||
| Q3 24 | $12.8M | $11.0M | ||
| Q2 24 | $24.9M | $1.0M | ||
| Q1 24 | $14.6M | $11.2M |
自由现金流CCBGPBYI
| Q4 25 | $80.0M | $14.4M | ||
| Q3 25 | $19.8M | $9.7M | ||
| Q2 25 | $30.8M | $14.1M | ||
| Q1 25 | $19.5M | $3.6M | ||
| Q4 24 | $54.9M | $15.6M | ||
| Q3 24 | $10.5M | $11.0M | ||
| Q2 24 | $23.0M | $1.0M | ||
| Q1 24 | $12.4M | — |
自由现金流率CCBGPBYI
| Q4 25 | 126.1% | 19.1% | ||
| Q3 25 | 30.1% | 17.7% | ||
| Q2 25 | 48.7% | 26.8% | ||
| Q1 25 | 31.7% | 7.7% | ||
| Q4 24 | 91.7% | 26.4% | ||
| Q3 24 | 17.6% | 13.7% | ||
| Q2 24 | 39.0% | 2.1% | ||
| Q1 24 | 22.0% | — |
资本支出强度CCBGPBYI
| Q4 25 | 12.0% | 0.0% | ||
| Q3 25 | 2.6% | 0.0% | ||
| Q2 25 | 2.9% | 0.0% | ||
| Q1 25 | 3.9% | 0.1% | ||
| Q4 24 | 14.5% | 0.0% | ||
| Q3 24 | 3.8% | 0.0% | ||
| Q2 24 | 3.3% | 0.0% | ||
| Q1 24 | 4.0% | 0.0% |
现金转化率CCBGPBYI
| Q4 25 | 6.39× | — | ||
| Q3 25 | 1.35× | 1.10× | ||
| Q2 25 | 2.17× | 2.41× | ||
| Q1 25 | 1.30× | 1.21× | ||
| Q4 24 | 4.86× | — | ||
| Q3 24 | 0.97× | 0.54× | ||
| Q2 24 | 1.76× | — | ||
| Q1 24 | 1.17× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
